Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection : AXL as a Therapeutic Target for COVID-19

Phosphatidylserine (PS) receptors are PS binding proteins that mediate uptake of apoptotic bodies. Many enveloped viruses utilize this PS/PS receptor mechanism to adhere to and internalize into the endosomal compartment of cells and this is termed apoptotic mimicry. For viruses that have a mechanism(s) of endosomal escape, apoptotic mimicry is a productive route of virus entry. We evaluated if PS receptors serve as cell surface receptors for SARS-CoV-2 and found that the PS receptors, AXL, TIM-1 and TIM-4, facilitated virus infection when low concentrations of the SARS-CoV-2 cognate receptor, ACE2, was present. Consistent with the established mechanism of PS receptor utilization by other viruses, PS liposomes competed with SARS-CoV-2 for binding and entry. We demonstrated that this PS receptor enhances SARS-CoV-2 binding to and infection of an array of human lung cell lines and is an under-appreciated but potentially important host factor facilitating SARS-CoV-2 entry.

Errataetall:

UpdateIn: PLoS Pathog. 2021 Nov 19;17(11):e1009743. - PMID 34797899

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - year:2021

Enthalten in:

bioRxiv : the preprint server for biology - (2021) vom: 24. Juni

Sprache:

Englisch

Beteiligte Personen:

Bohan, Dana [VerfasserIn]
Ert, Hanora Van [VerfasserIn]
Ruggio, Natalie [VerfasserIn]
Rogers, Kai J [VerfasserIn]
Badreddine, Mohammad [VerfasserIn]
Aguilar Briseño, José A [VerfasserIn]
Rojas Chavez, Roberth Anthony [VerfasserIn]
Gao, Boning [VerfasserIn]
Stokowy, Tomasz [VerfasserIn]
Christakou, Eleni [VerfasserIn]
Micklem, David [VerfasserIn]
Gausdal, Gro [VerfasserIn]
Haim, Hillel [VerfasserIn]
Minna, John [VerfasserIn]
Lorens, James B [VerfasserIn]
Maury, Wendy [VerfasserIn]

Links:

Volltext

Themen:

ACE2
AXL
Apoptotic mimicry
Bemcentinib
COVID19
Phosphatidylserine receptor
Preprint
SARS-CoV-2
TIM-1
TMPRSS2
Viral entry

Anmerkungen:

Date Revised 14.01.2022

published: Electronic

UpdateIn: PLoS Pathog. 2021 Nov 19;17(11):e1009743. - PMID 34797899

Citation Status PubMed-not-MEDLINE

doi:

10.1101/2021.06.15.448419

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM327066598